Summary
In spite of dietary treatment, the infants of pregnant patients with abnormal glucose tolerance have hyperinsulinism and diabetogenic fetopathy in 10 to 36% of cases. Those patients, who require insulin to prevent from fetopathy cannot be reliably selected by maternal parameters such as blood glucose and glycosylated hemoglobin values. We recommend the measurement of amniotic fluid insulin between the 28 and 32 weeks of pregnancy to differentiate whether the fetus is compromised or not. Subjects with values above the 97th centile require insulin therapy. Inadequate insulin dosage or delayed fetal hyperinsulinism can be discovered by checking the amniotic fluid insulin level at 33 to 36 weeks. In a total of 88 gestational diabetic patients 19 had raised amniotic fluid insulin levels indicating the onset of diabetic fetopathy at an early stage. Diabetic patients with raised amniotic fluid insulin levels needed large doses of insulin, namely 64.6 ± 29.5 (Mean ± SD) U/24 h. This treatment reduced mean blood glucose levels from 98 ± 9 (Mean ± SD) mg/dl to 82 ± 10 mg/dl and was sufficient to prevent from diabetic fetopathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burke BJ, Sheriff RJ, Savage PE, Dixon HG (1979) Diabetic twin pregnancy: An unequal result. Lancet 1:1372–1373
Coustan DR, Lewis SB (1978) Insulin therapy for gestational diabetes. Obstet Gynecol 51:306–310
Dempe A, Michaelis D, Heinke P, Franke D, Seitz W, Barthel D, Bauch K (1978) Häufigkeit des Gestationsdiabetes sowie der Verä nderungen der Insulinsekretion bei Schwangeren. 1. Mitteilung: Untersuchungen von diabetesverdächtigen Schwangeren mittels des Glucoseinfusionstests (GIT). Zentralbl Gynäkol 100:1559–1565
Drexel H, Bichler A, Breier CH, Lisch HJ, Renner H, Sailer S (1983) Diagnose eines Schwangerschaftsdiabetes. Treffsicherheit und prognostische Wertigkeit. Wien Klin Wochenschr 95:165–168
Hinckers HJ (1978) Kindsgeschlecht und Glukosetoleranz: Untersuchungen mittels des kontinuierlich registrierten i. v. Glukosetoleranztest (i. v.-Glucogramm). Gynäkologe 11:99–102
Hohenauer H (1980) Intrauterine Wachstumskurven für den Deutschen Sprachraum. Z Geburtshilfe Perinatol 184:167–179
Hollingsworth DR (1983) Alterations of maternal metabolism in normal and diabetic pregnancies: Differences in insulin dependent and gestational diabetes. Am J Obstet Gynecol 146:417–429
Hommel G, Muck BR (1977) Ein diskriminanzanalytischer Ansatz zur Beurteilung der Glukosetoleranz Schwangerer anhand von Seruminsulin Verlaufsbeobachtungen. Arch Gynäkol 223:315–321
Jackson WPU, Woolf N (1958) Maternal prediabetes as a cause of the unexplained stillbirth. Diabetes 7:446–451
Lang N, Bollmann O, Hinckers HJ, Schlebusch H (1978) Diagnostik und klinische Bedeutung des Gestationsdiabetes. Gynäkologe 11:78–87
Muck BR, Hommel G (1977) Plasma insulin response following intravenous glucose in gestational diabetes. Arch Gynäkol 223:259–268
Newman RL, Tutera G (1976) The glucose-insulin ratio in amniotic fluid. Obstet Gynecol 47:599–601
O'Sullivan JB, Gellis SS, Dandrow RV, Tenney BO (1966) The potential diabetic and her treatment in pregnancy. Obstet Gynecol 27:683–689
O'Sullivan JB, Mahan CM, Charles D, Dandrow RV (1974) Medical treatment of the gestational diabetic. Obstet Gynecol 43:817–821
Persson B, Lunell NO (1975) Metabolic control in diabetic pregnancy. Variations in plasma concentrations of glucose, free fatty acids, glycerol, ketone bodies insulin and human chorionic sommatomammotropin during the last trimester. Am J Obstet Gynecol 122:737–745
Persson B, Heding LG, Lunell NO, Pschera H, Stangenberg M, Wagner J (1982) Fetal beta cell function in diabetic pregnancy. Amniotic fluid concentrations of proinsulin, insulin and C-peptide during the last trimester of pregnancy. Am J Obstet Gynecol 144:455–459
Reiher H, Woltansky P, Hahn J (1981) Effect of glucose on human fetal pancreatic tissue in vitro. Acta Biol Med Ger 40:61–63
Roversi GD, Gargiolog M, Nicoline U, Pedretti E, Marini A, Barbarani V, Peneff P (1979) A new approach to the treatment of diabetic pregnant women. Report of 479 cases seen from 1963–1975. Am J Obstet Gynecol 135:567–576
Salzberger M, Liban E (1975) Diabetes and antenatal fetal death. Isr J Med Sci 11:623–628
Thalme B, Edström K (1974) Intravenous glucose tolerance test and its relation to a scoring system for the degree of diabetic fetopathy in newborn infants. J Perinat Med 2:233–242
Turner RC, Harris E, Bloom SR, Uren C (1977) Relation of fasting plasma glucose concentration to plasma insulin and glucagon concentrations. Studies in latent diabetics and women who have produced large for-dates babies. Diabetes 26:166–171
Tyson JE, Hock RH (1976) Gestational and pregestational diabetes: An approach to therapy. Am J Obstet Gynecol 125:1009–1027
Weiss PAM, Lichtenegger W, Winter R, Pürstner P (1978) Insulin levels in amniotic fluid. Management of pregnancy in diabetes. Obstet Gynecol 51:393–398
Weiss PAM (1979) Die Überwachung des Ungeborenen bei Diabetes mellitus anhand von Fruchtwasserinsulinwerten. Wien Klin Wochenschr 91:293–304
Weiss PAM, Pürstner P, Winter R, Lichtenegger W (1984) Insulin levels in amniotic fluid of normal and abnormal pregnancies. Obstet Gynecol 63:371–375
Weiss PAM, Hofmann H, Pürstner P, Winter R, Lichtenegger W (1984) Fetal insulin balance: Gestational diabetes and postpartal screening. Obstet Gynecol 64:65–68
Weiss PAM, Hofmann H, Winter R, Pürstner P, Lichtenegger W (1984) Gestational diabetes and screening during pregnancy. Obstet Gynecol 63: 776–780
White P (1974) Diabetes mellitus in pregnancy. Clin Perinatol 1:331–347
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weiss, P.A.M., Hofmann, H.M., Winter, R.R. et al. Diagnosis and treatment of gestational diabetes according to amniotic fluid insulin levels. Arch. Gynecol. 239, 81–91 (1986). https://doi.org/10.1007/BF02133967
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02133967